Capsule Endoscopy Market by Product, Application, End-Use

Description

List of Tables

[196 Pages Report] The Capsule Endoscopy Market size was estimated at USD 554.66 million in 2023 and expected to reach USD 606.57 million in 2024, at a CAGR 9.80% to reach USD 1,067.37 million by 2030.

Capsule endoscopy is a modern diagnostic tool that allows for the visualization and examination of the gastrointestinal tract using a pill-sized capsule equipped with a camera. This market comprises manufacturers, healthcare providers, and patients utilizing the device for gastrointestinal diagnosis. The increasing prevalence of gastrointestinal disorders globally and the significant adoption of minimally invasive surgical interventions contribute positively to market growth. Concerns associated with capsule retention rate, adverse effects, and incomplete small bowl examination results are significant hindrances in markets. Opportunities within this market involve growing initiatives to improve healthcare infrastructure and increase awareness of gastrointestinal disorders. In addition, technological advancements coupled with better-designed wireless capsules are expected to create growth in the market.

KEY MARKET STATISTICS
Base Year [2023]	USD 554.66 million
Estimated Year [2024]	USD 606.57 million
Forecast Year [2030]	USD 1,067.37 million
CAGR (%)	9.80%

Product: Growing adoption of capsule endoscopes due to their minimally invasive nature

Capsule endoscopes are tiny, pill-sized cameras that patients swallow. These devices travel through the gastrointestinal tract, capturing images and sending them wirelessly for medical diagnosis. These are preferred for their ability to visualize the small intestine, an area that is difficult to reach with traditional endoscopes. Patients opt for capsule endoscopes due to their minimally invasive nature, with no need for sedation. The ease of the procedure and the lack of discomfort are significant benefits, making it suitable for children and elderly patients. Systems in the context of capsule endoscopy include the necessary supporting hardware and software used to record, view, and analyze the data captured by the capsule endoscopes. Such systems consist of workstations, data recorders, receiver belts, and software for image analysis. These are critical for collecting and managing the vast amounts of data generated by capsule endoscopes. Advanced software helps in the detailed examination of images and supports better diagnosis. User-friendly interfaces are valued by healthcare providers for streamlining the endoscopic process.

Application: Expanding usage of capsule endoscopes for managing obscure gastrointestinal bleeding (OGIB)

Crohn's disease is a type of inflammatory bowel disease (IBD) that affects any part of the gastrointestinal tract. Capsule endoscopy is particularly beneficial in diagnosing and assessing the extent and activity of Crohn's disease, as it can visualize areas of the small intestine that are difficult to reach with traditional endoscopy procedures. The non-invasive nature of capsule endoscopy provides a more patient-friendly option for continuous monitoring of disease progression or response to therapy. Obscure gastrointestinal bleeding (OGIB) refers to bleeding that occurs from an unknown source in the gastrointestinal tract. Capsule endoscopy is critical in diagnosing OGIB, as it can detect bleeding sources in the small intestine that are not visible through traditional endoscopy or colonoscopy. Small intestine tumor diagnosis is a challenging area in gastrointestinal medicine due to the limited accessibility of the small intestine with conventional endoscopic equipment. Capsule endoscopy is a crucial tool in detecting benign and malignant tumors within the small intestine. It helps in early diagnosis and plays a vital role where other imaging studies don't provide adequate visibility or conclusive results. The preference for capsule endoscopy is shaped largely by its ability to access and visualize remote parts of the small bowel. With Crohn's Disease, the long-term monitoring aspect is paramount, while in OGIB, the acute diagnostic capability to identify the source of bleeding is the priority. For small intestine tumors, the emphasis is on early and accurate detection.

End-Use: Increasing usage of capsule endoscopes by hospitals for more complicated cases that require a multi-disciplinary approach

Ambulatory surgery centers are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. ASCs are increasingly preferred for capsule endoscopy because they offer convenient and cost-effective services without the need for hospital admission. The preference for ASCs stems from the expedited patient turnover, reduced risk of hospital-acquired infections, and their ability to provide specialized care. Hospitals serve as the primary setting for a wide range of endoscopic procedures, including capsule endoscopy. They are preferred for more complicated cases that require a multi-disciplinary approach or might require emergency intervention. Hospitals have a broad infrastructure that tends to incorporate various diagnostic and therapeutic services, which work in conjunction with capsule endoscopy outcomes if further treatment is needed.

Regional Insights

In the Americas, the United States is a key market for capsule endoscopy, driven by advanced healthcare infrastructure, a substantial focus on research and development, and a high prevalence of gastrointestinal diseases. The adoption of capsule endoscopy is supported by favorable reimbursement policies, less readily seen in other regions. Canada and South American countries also contribute to the market, though to a lesser extent due to variances in healthcare expenditure and technological adoption rates. The Asia-Pacific is witnessing rapid growth in the capsule endoscopy market, largely fueled by an increasing aging population, growing healthcare infrastructure, and rising incidences of gastrointestinal disorders. Countries such as Japan, South Korea, and China are at the forefront, with Japan featuring some of the earliest adopters of capsule endoscopy technology due to its innovation-friendly healthcare system. The Europe, Middle East, and Africa (EMEA) region presents a diverse market for capsule endoscopy. Western European countries have a mature healthcare sector with high adoption of novel diagnostic technologies, including capsule endoscopy, aided by strong healthcare systems and wide insurance coverage. In Middle Eastern countries, there is a growing demand for healthcare services and medical devices, including capsule endoscopy, driven by increasing healthcare investments and modernization of healthcare facilities.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Capsule Endoscopy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Capsule Endoscopy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Capsule Endoscopy Market, highlighting leading vendors and their innovative profiles. These include AdvinHealthcare, Ambu A/S, Anx Robotica Corp., Biocam Sp. z o.o., Boston Scientific Corporation, CapsoVision Inc., Check-Cap Ltd. by Symetryx Corp., Chongqing Jinshan Science & Technology (Group) Co., Ltd, Covestro AG, Duomed Group, Fujifilm Holding Corporation, Intromedic co., Ltd, Medtronic PLC, MU Ltd., Olympus Corporation, RF Systems Lab, Shangxian Minimal Invasive Inc., and STERIS Corporation.

Market Segmentation & Coverage

This research report categorizes the Capsule Endoscopy Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Capsule Endoscopes
- Systems

Application
- Crohn's Disease
- Obscure Gastrointestinal Bleeding
- Small Intestine Tumor

End-Use
- Ambulatory Surgery Centers
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Capsule Endoscopy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Capsule Endoscopy Market?

3. What are the technology trends and regulatory frameworks in the Capsule Endoscopy Market?

4. What is the market share of the leading vendors in the Capsule Endoscopy Market?

5. Which modes and strategic moves are suitable for entering the Capsule Endoscopy Market?

Product Code: MRR-3A2E844FDE44

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of gastrointestinal disorders globally
  - 5.1.1.2. Significant adoption of minimally invasive surgical interventions
- 5.1.2. Restraints
  - 5.1.2.1. Concerns associated with the capsule retention rate
- 5.1.3. Opportunities
  - 5.1.3.1. Technological advancements coupled with better-designed wireless capsules
  - 5.1.3.2. Growing initiatives to improve healthcare infrastructure and increase awareness of gastrointestinal disorders
- 5.1.4. Challenges
  - 5.1.4.1. Adverse effects and incomplete small bowl examination
5.2. Market Segmentation Analysis
- 5.2.1. Product: Growing adoption of capsule endoscopes due to their minimally invasive nature
- 5.2.2. Application: Expanding usage of capsule endoscopes for managing obscure gastrointestinal bleeding (OGIB)
- 5.2.3. End-Use: Increasing usage of capsule endoscopes by hospitals for more complicated cases that require a multi-disciplinary approach
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Capsule Endoscopy Market, by Product

6.1. Introduction
6.2. Capsule Endoscopes
6.3. Systems

7. Capsule Endoscopy Market, by Application

7.1. Introduction
7.2. Crohn's Disease
7.3. Obscure Gastrointestinal Bleeding
7.4. Small Intestine Tumor

8. Capsule Endoscopy Market, by End-Use

8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals

9. Americas Capsule Endoscopy Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Capsule Endoscopy Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Capsule Endoscopy Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. NexOptic Technology Corp. Signs MOU with IntroMedic, A Global Capsule Endoscopic Imaging Corporation
- 12.3.2. AnX Robotica Announces Expanded Indications of Magnetically Controlled Capsule Endoscopy
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio